NCCN Foundation awards leading young investigators advancing cancer research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network and the NCCN Foundation announced five new recipients for the 10th annual NCCN Foundation Young Investigator Awards Program.

The honorees will receive up to $150,000 in funding to study ways to improve care and help find cures for people with breast, colorectal, pancreatic, and small cell lung cancer, as well as pediatric acute myeloid leukemia. The NCCN Oncology Research Program managed the selection process and will oversee the projects, which will each extend for the next two years.

The 2020 NCCN Foundation YIA recipients are:

  • Agnieszka Czechowicz, assistant professor of pediatrics, Stanford University School of Medicine: “Development of anti-hKIT Chimeric Antigen Receptor T-Cells as a Dual Hematopoietic Stem Cell Transplantation Conditioning and Immunotherapeutic Agent for Cure of Pediatric Acute Myeloid Leukemia.”

  • Wade T. Iams, assistant professor of medicine, Vanderbilt University Medical Center: “Quantifying Minimal Residual Disease in Patients with Small Cell Lung Cancer.”

  • Shivan Mehta, assistant professor of medicine, University of Pennsylvania: “Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting.”

  • Mustafa Raoof, assistant clinical professor, City of Hope Beckman Research Institute: “Targeting Transcription-Replication Conflicts in KRAS-driven Pancreatic Cancer.”

  • Jennifer Y. Sheng, assistant professor in oncology, Johns Hopkins University School of Medicine: “An Adaptive Nutrition and Exercise Weight loss (A-NEW) Study for Breast Cancer Survivors.”

Table of Contents

YOU MAY BE INTERESTED IN

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer. 
Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login